|

Triapine Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: 3-AP, 3-Apct, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, OCX-0191, OCX-191 +2 more

Pipeline

Phase 1: 1

Top Sponsors

  • Northwestern University1

Indications

  • Recurrent WHO Grade 2 Glioma1
  • Recurrent WHO Grade 4 Glioma1
  • Recurrent WHO Grade 3 Glioma1
  • Recurrent Glioblastoma, IDH-Wildtype1
  • Cancer1

Chicago, Illinois1 trial

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

Northwestern University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.